Skip to main content

Diabetic Medicine 2013; 30(12): 1510-1511

The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis—what happens next? A personal viewpoint

R. E. J. Ryder1, P. Sen Gupta1,2, K. Y. Thong1 on behalf of the ABCD nationwide exenatide* and liraglutide audit contributors

1Department of Diabetes and Endocrinology, City Hospital, Birmingham, UK

2Diabetes Research Group, King’s College, London, UK

*The exenatide audit contributors are listed in reference 2.

The liraglutide audit contributors are listed in reference 3.

Resource taxonomy
Clinical taxonomy
Listing status